Pathway's 150M-Parameter Model Breaks the ARC-AGI-1 Cost-Efficiency Frontier
Pathway, an AI lab building a Post-Transformer architecture and models, today published benchmark results for BDH-CQ, a 150-million-parameter reasoning model. BDH-CQ scored 29.5% pass@2 on the public ARC-AGI-1 evaluation set at a computed inference cost of $0.0007 per task. Thanks to a new approach to reasoning, BDH-CQ runs approximately 11 times as cheaply per task as GPT 5.6 Luna (Low), even after accounting for OpenAI’s 80% price cut of 5.6 Luna on July 30th. Luna scores 34.2% against BDH-CQ's 29.5%, a modest accuracy gain at 11 times the cost.
Pathway to Deliver New Class of Adaptive and Continuously Learning AI Systems with AWS and NVIDIA Technologies
Pathway, the data company building live AI that thinks in real-time like humans do, today announced that its groundbreaking post-Transformer BDH (Dragon Hatchling) architecture now runs on NVIDIA AI infrastructure and AWS’s cloud and AI tech stack, enabling a new class of adaptive and continuously learning AI systems.
Pathway Launches a New “Post-Transformer” Architecture That Paves the Way for Autonomous AI
Pathway, the data company building live AI that thinks in real-time like humans do, is today introducing Baby Dragon Hatchling (BDH), a new “post-Transformer” architecture that addresses one of the most significant barriers to autonomous artificial intelligence (AI): the inability to generalize over time.
Pathway Expands Medical AI Platform with Drug Reference and Interaction Checker
Pathway today announced the launch of a fully integrated drug reference and drug-drug interaction checker within its AI-powered medical knowledge platform. Clinicians can now access comprehensive medication information for over 2,000 drugs and screen for interactions directly within the same interface they already use for clinical guidance.
Pathway Sets a New Benchmark for Specialty Medical AI with Transparent Just-in-Time Reasoning
Pathway today announced that its proprietary large-language model (LLM) scored 96% on a validated set of United States Medical Licensing Examination (USMLE) questions, the highest accuracy yet reported for a specialized medical AI. The result strengthens Pathway’s position as a leading evidence-based decision-support tool for frontline clinicians.
Pathway Raises $5M to Expand Its AI-Powered Medical Knowledge Platform
Pathway, the AI-driven medical knowledge platform, has secured $5 million in seed funding to advance its solutions to information overload among healthcare professionals. Pathway distills practice guidance from millions of evidence-based sources into concise summaries, helping clinicians stay up-to-date and provide efficient, high-quality care.
